We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Drugged up

13 March 2006 By Nina Koeppen

The German drugs group may have firmly rejected the E77 a share cash bid. But this looks like an emotional reaction. The bid looks pretty fair. It won t be enough for Schering simply to dismiss Merck. It needs to deliver more value to investors.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)